Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Indian J Microbiol ; 63(4): 513-519, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38031618

RESUMO

Bovine viral diarrheal virus (BVDV) and bovine coronavirus (BCoV) are prevalent viral infections in buffalo calves that result in significant economic losses globally. However, Bovine picobirnavirus (BPBV) Group I and II has been an emerging causes of gastrointestinal infection as has been detected with mixed of BVDV as well as BCV. To combat economic losses and viral infection, a rapid and innovative multiplex-PCR assay (M-PCR) was developed to simultaneously identify BVDV, BCV, and BPBV. The assay employed three primer pairs, each specific to a particular virus. Notably, the primers for BCV and BVDV, targeting the transmembrane (M) Mebus gene and 5'UTR genes, respectively, were self-designed. To validate the assay, 300 samples of buffalo calf feces were subjected to the standardized multiplex PCR. The results demonstrated that 54 (18%) samples tested positive for multiple viruses, with 16.67% samples infected by BVDV, 0.9% by BCoV, and 0.13% by BPBV, as detected by the M-PCR assay. In summary, this developed assay is characterized by high specificity, sensitivity, throughput, and speed, enabling the simultaneous detection of the three viruses in a single reaction tube. Consequently, it holds potential for epidemiological investigations. It is worth noting that, to the best of our knowledge, this is the first reported multiplex assay for the worldwide detection of BVDV, BCoV, and BPBV. This novel assay promises to aid in the detection of mixed infections in the gastrointestinal tract.

2.
J Virol ; 86(15): 8337-8, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22787269

RESUMO

In this article, we document the first complete genome sequence of an isolate of bluetongue virus serotype 16 (BTV16) from a goat in India. The virus was isolated from an in-contact goat from an animal farm in Chennai where clinical disease occurs in sheep. The total size of the genome is 19,185 bp. The information provided for full-length sequences of all 10 segments will help in understanding the geographical origin and transmission of the Indian isolate of BTV16 as well as its comparison with global isolates of BTV16 of sheep, cattle, and other host species origins.


Assuntos
Vírus Bluetongue/genética , Genoma Viral , Animais , Sequência de Bases , Vírus Bluetongue/patogenicidade , Bovinos/virologia , Cabras/virologia , Índia , Dados de Sequência Molecular , Análise de Sequência de DNA , Ovinos/virologia
3.
J Nanosci Nanotechnol ; 21(6): 3513-3523, 2021 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-34739802

RESUMO

Bluetongue (BT) disease is a noncontagious disease of domestic and wild ruminants (mainly sheep, cattle, deer) caused by the bluetongue virus (BTV) which is an orbivirus of the Reoviridae family and transmitted by vector Culicoides biting midges. It is a reportable disease of considerable socioeconomic concern and of major importance for the international trade of animals and animal products. Conventional diagnostic methods, such as virus propagation and isolation, immunoassays and also various molecular methods have been developed for the detection of the BTV. Here, we present a novel, rapid and pen-side test for the detection of BTV using multiwalled carbon nanotube (MWCNTs) based immunosensor. Though it is not reported yet. The MWCNTs were prepared, characterized and functionalized with carboxyl group. Viral antibodies were conjugated successfully with functionalized MWCNTs and coated on screen printed carbon electrode (SPCE). These SPCE were evaluated by using electrochemical sensor with an antigen specific to BTV antibodies, resulted in the self-assembled layer of antigen-antibody on the surface of SPCE. The approach described in the present study is a prototype for the development of simple and economic diagnostic tool which will provide the routine screening of BT disease at the door of farmers, thereby increasing the income of farmers by decreasing the cost of diagnosis.


Assuntos
Técnicas Biossensoriais , Vírus Bluetongue , Bluetongue , Cervos , Nanotubos de Carbono , Animais , Bluetongue/diagnóstico , Bovinos , Comércio , Imunoensaio , Internacionalidade , Ovinos
4.
Curr Top Med Chem ; 20(11): 963-981, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32141419

RESUMO

Bioengineered polymers and nanomaterials have emerged as promising and advanced materials for the fabrication and development of novel biosensors. Nanotechnology-enabled biosensor methods have high sensitivity, selectivity and more rapid detection of an analyte. Biosensor based methods are more rapid and simple with higher sensitivity and selectivity and can be developed for point-of-care diagnostic testing. Development of a simple, sensitive and rapid method for sorbitol detection is of considerable significance to efficient monitoring of diabetes-associated disorders like cataract, neuropathy, and nephropathy at initial stages. This issue encourages us to write a review that highlights recent advancements in the field of sorbitol detection as no such reports have been published till the date. The first section of this review will be dedicated to the conventional approaches or methods that had been playing a role in detection. The second part focused on the emerging field i.e. biosensors with optical, electrochemical, piezoelectric, etc. approaches for sorbitol detection and the importance of its detection in healthcare application. It is expected that this review will be very helpful for readers to know the different conventional and recent detection techniques for sorbitol at a glance.


Assuntos
Técnicas Biossensoriais/métodos , Nanoestruturas/química , Polímeros/química , Sorbitol/análise , Catarata/diagnóstico , Nefropatias Diabéticas/diagnóstico , Neuropatias Diabéticas/diagnóstico , Técnicas Eletroquímicas , Setor de Assistência à Saúde , Humanos , Proteínas Imobilizadas/química , L-Iditol 2-Desidrogenase/metabolismo , Espectrofotometria , Propriedades de Superfície
5.
Curr Top Med Chem ; 20(11): 982-1008, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32196449

RESUMO

Inflammatory Bowel Disease (IBD) is an umbrella term used to describe disorders that involve Crohn's disease (CD), ulcerative colitis (UC) and pouchitis. The disease occurrence is more prevalent in the working group population which not only hampers the well being of an individual but also has negative economical impact on society. The current drug regime used therapy is very costly owing to the chronic nature of the disease leading to several side effects. The condition gets more aggravated due to the lower concentration of drug at the desired site. Therefore, in the present scenario, a therapy is needed which can maximize efficacy, adhere to quality of life, minimize toxicity and doses, be helpful in maintaining and stimulating physical growth of mucosa with minimum disease complications. In this aspect, nanotechnology intervention is one promising field as it can act as a carrier to reduce toxicity, doses and frequency which in turn help in faster recovery. Moreover, nanomedicine and nanodiagnostic techniques will further open a new window for treatment in understanding pathogenesis along with better diagnosis which is poorly understood till now. Therefore the present review is more focused on recent advancements in IBD in the application of nanotechnology.


Assuntos
Anti-Inflamatórios/química , Portadores de Fármacos/química , Fármacos Gastrointestinais/química , Doenças Inflamatórias Intestinais/tratamento farmacológico , Nanopartículas/química , Polímeros/química , Administração Oral , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/efeitos adversos , Transporte Biológico , Química Farmacêutica , Quimioterapia Combinada , Absorção Gastrointestinal , Fármacos Gastrointestinais/administração & dosagem , Fármacos Gastrointestinais/efeitos adversos , Humanos , Metais/química , Mucosa/efeitos dos fármacos , Nanomedicina , Qualidade de Vida , RNA Interferente Pequeno/metabolismo , Terapêutica com RNAi
6.
Curr Top Med Chem ; 20(11): 1029-1041, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32148195

RESUMO

Metal nanoparticles (NPs) are described in the nanoscale and made from either pure metals or their compounds such as oxides. Metallic NPs have certain indistinct functional groups due to which these can bind with any type of ligand, antibody and drugs. Organic polymers, which conduct electricity, are called conducting polymers (intrinsically conducting polymers). They behave like semiconductors by exhibiting metallic conductivity. Process-ability is the major advantage of conducting polymers. Nanocomposite is a novel material having nano-fillers scattered in a matrix with morphology and interfacial characteristics of nano-composites including their individual property that influence their characteristics. Conducting polymers and NP composites can enhance the rate of electron transport between the current collector material (electrode) and the electrolyte; therefore they have been employed in the construction of improved electrochemical sensors such as amperometric, catalytic and potentiodynamic affinity sensors.


Assuntos
Técnicas Biossensoriais/instrumentação , Glicemia/análise , Técnicas Eletroquímicas/instrumentação , Nanopartículas Metálicas/química , Nanocompostos/química , Polímeros/química , Condutividade Elétrica , Eletrodos , Humanos , Limite de Detecção , Metais/química , Óxidos/química , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Propriedades de Superfície
7.
Curr Top Med Chem ; 20(11): 915-962, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32209041

RESUMO

BACKGROUND: Emerging viral zoonotic diseases are one of the major obstacles to secure the "One Health" concept under the current scenario. Current prophylactic, diagnostic and therapeutic approaches often associated with certain limitations and thus proved to be insufficient for customizing rapid and efficient combating strategy against the highly transmissible pathogenic infectious agents leading to the disastrous socio-economic outcome. Moreover, most of the viral zoonoses originate from the wildlife and poor knowledge about the global virome database renders it difficult to predict future outbreaks. Thus, alternative management strategy in terms of improved prophylactic vaccines and their delivery systems; rapid and efficient diagnostics and effective targeted therapeutics are the need of the hour. METHODS: Structured literature search has been performed with specific keywords in bibliographic databases for the accumulation of information regarding current nanomedicine interventions along with standard books for basic virology inputs. RESULTS: Multi-arrayed applications of nanomedicine have proved to be an effective alternative in all the aspects regarding the prevention, diagnosis, and control of zoonotic viral diseases. The current review is focused to outline the applications of nanomaterials as anti-viral vaccines or vaccine/drug delivery systems, diagnostics and directly acting therapeutic agents in combating the important zoonotic viral diseases in the recent scenario along with their potential benefits, challenges and prospects to design successful control strategies. CONCLUSION: This review provides significant introspection towards the multi-arrayed applications of nanomedicine to combat several important zoonotic viral diseases.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Vacinas Virais/química , Zoonoses Virais/diagnóstico , Zoonoses Virais/prevenção & controle , Zoonoses Virais/terapia , Vírus/efeitos dos fármacos , Animais , Animais Selvagens , Técnicas Biossensoriais , Portadores de Fármacos/química , Composição de Medicamentos , Liberação Controlada de Fármacos , Humanos , Nanomedicina , Nanopartículas/química , Polímeros/química , Polímeros/metabolismo , Transfecção , Vírus/metabolismo
8.
Curr Pharm Des ; 25(13): 1554-1579, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31218956

RESUMO

BACKGROUND: Mycobacterium group contains several pathogenic bacteria including M. tuberculosis where the emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) is alarming for human and animal health around the world. The condition has further aggravated due to the speed of discovery of the newer drugs has been outpaced by the rate of resistance developed in microorganisms, thus requiring alternative combat strategies. For this purpose, nano-antimicrobials have emerged as a potential option. OBJECTIVE: The current review is focused on providing a detailed account of nanocarriers like liposome, micelles, dendrimers, solid lipid NPs, niosomes, polymeric nanoparticles, nano-suspensions, nano-emulsion, mesoporous silica and alginate-based drug delivery systems along with the recent updates on developments regarding nanoparticle-based therapeutics, vaccines and diagnostic methods developed or under pipeline with their potential benefits and limitations to combat mycobacterial diseases for their successful eradication from the world in future. RESULTS: Distinct morphology and the underlying mechanism of pathogenesis and resistance development in this group of organisms urge improved and novel methods for the early and efficient diagnosis, treatment and vaccination to eradicate the disease. Recent developments in nanotechnology have the potential to meet both the aspects: nano-materials are proven components of several efficient targeted drug delivery systems and the typical physicochemical properties of several nano-formulations have shown to possess distinct bacteriocidal properties. Along with the therapeutic aspects, nano-vaccines and theranostic applications of nano-formulations have grown in popularity in recent times as an effective alternative means to combat different microbial superbugs. CONCLUSION: Nanomedicine holds a bright prospect to perform a key role in global tuberculosis elimination program.


Assuntos
Antituberculosos/farmacologia , Tuberculose Extensivamente Resistente a Medicamentos , Mycobacterium tuberculosis , Nanomedicina/tendências , Tuberculose Resistente a Múltiplos Medicamentos , Animais , Sistemas de Liberação de Medicamentos , Humanos
9.
Virus Res ; 173(2): 336-43, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23353779

RESUMO

The genome of bluetongue virus (BTV) consists of 10 segments. Of these seg-2 encoded VP2 is the major serotype determining protein, and seg-6 encoded VP5 protein enhances the protective neutralizing activity of VP2 protein inducing higher serotype specific antibody titer than the VP2 alone. Out of the twenty-six BTV serotypes found worldwide, 22 were reported from different states of India. These include serotype 21 which was recently isolated from Andhra Pradesh, and was involved in a severe outbreak of bluetongue in Indian native sheep. BTV21 (KMNO-7) and BTV16 were circulating at the same time. This co-circulation, along with the fact that the virus genome is segmented, provides an opportunity for these two isolates of different serotypes to simultaneously infect the same animal, and even the same cell or a same vector with the potential for generation of reassortant viruses. This study was carried out to provide some insights into the outbreak. We carried out full length sequencing of genome seg-2 and seg-6 of Indian isolates VJW64 (BTV16) and KMNO-7 (BTV21). Detailed phylogenetic analysis revealed that genome seg-6 of Indian isolate KMNO-7 (BTV21) clusters with isolates of BTV16 showing maximum nucleotide similarity of 97.6% with TUR/2000/02 isolate of BTV16, which is much more than it shows with any isolate of BTV21. KMNO-7 (BTV21) significantly diverged from original strain of BTV21, and is a reassortant strain having acquired seg-6 from an isolate of BTV16. This study provides some useful insights into the epidemiology of the bluetongue disease, and undermines serotyping on genome seg-6 basis.


Assuntos
Vírus Bluetongue/isolamento & purificação , Bluetongue/epidemiologia , RNA Viral/genética , Vírus Reordenados/isolamento & purificação , Animais , Bluetongue/virologia , Vírus Bluetongue/classificação , Vírus Bluetongue/genética , Análise por Conglomerados , Surtos de Doenças , Evolução Molecular , Índia/epidemiologia , Dados de Sequência Molecular , Filogenia , Vírus Reordenados/classificação , Vírus Reordenados/genética , Análise de Sequência de DNA , Homologia de Sequência , Ovinos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA